(Q34666836)

3 August 2017

Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunities (English)

1 reference

3 August 2017

1 reference

6

Thomas Gasser

1 reference

3 August 2017

12

Werner Poewe

1 reference

3 August 2017

1

Daniela Berg

2 references

ORCID Public Data File 2021

3 August 2017

Walter Maetzler

4

object named as

Walter Maetzler

1 reference

3 August 2017

9

Wolfgang Oertel

1 reference

3 August 2017

2

Anthony E Lang

1 reference

3 August 2017

8

Anthony H Schapira

1 reference

3 August 2017

Charles Warren Olanow

11

object named as

C Warren Olanow

1 reference

3 August 2017

7

Andrew Siderowf

1 reference

3 August 2017

13

Matthew Stern

1 reference

3 August 2017

Ronald B Postuma

3

1 reference

3 August 2017

Guenther Deuschl

5

1 reference

3 August 2017

José A Obeso

10

1 reference

3 August 2017

11 April 2013

1 reference

3 August 2017

1 reference

3 August 2017

12

1 reference

3 August 2017

5

1 reference

3 August 2017

514-524

1 reference

Toward a redefinition of Parkinson's disease

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Revising the definition of Alzheimer's disease: a new lexicon.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Is alpha-synuclein in the colon a biomarker for premotor Parkinson's disease? Evidence from 3 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Milestones in PD genetics

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Charcot on Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

What features improve the accuracy of clinical diagnosis in Parkinson's disease: A clinicopathologic study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Prevalence of smell loss in Parkinson's disease--a multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Olfactory testing differentiates between progressive supranuclear palsy and idiopathic Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Olfactory function in Parkinson's disease subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Hyposmia in pure autonomic failure.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

alpha-Synucleinopathy in the human olfactory system in Parkinson's disease: involvement of calcium-binding protein- and substance P-positive cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Olfactory system pathology as a model of Lewy neurodegenerative disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Association of olfactory dysfunction with risk for future Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Olfactory dysfunction in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Is REM sleep behaviour disorder (RBD) a risk factor of dementia in idiopathic Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Insights into REM sleep behavior disorder pathophysiology in brainstem-predominant Lewy body disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

REM sleep behavior disorder and REM sleep without atonia in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Questionnaire-based assessment of pelvic organ dysfunction in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Constipation in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Assessment of voiding dysfunction in Parkinson's disease by the international prostate symptom score

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Urinary symptoms in Parkinson's disease: prevalence and associated factors.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Invited Article: Nervous system pathology in sporadic Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Medical records documentation of constipation preceding Parkinson disease: A case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Frequency of bowel movements and the future risk of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Reversal of visuospatial deficit on the Clock Drawing Test in Parkinson's disease by treatment with weak electromagnetic fields

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Ophthalmologic features of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Correlation between retinal morphological and functional findings and clinical severity in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

ERG and anatomical abnormalities suggesting retinopathy in dementia with Lewy bodies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Olfaction and color vision identify impending neurodegeneration in rapid eye movement sleep behavior disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Higher incidence of depression preceding the onset of Parkinson's disease: a register study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Depression in late life: review and commentary

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Biomarkers for the early detection of Parkinson's and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Ageing and Parkinson's disease: substantia nigra regional selectivity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Presymptomatic compensation in Parkinson's disease is not dopamine-mediated

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Prevalence of parkinsonian signs and associated mortality in a community population of older people.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Parkinsonian signs in older people: prevalence and associations with smoking and coffee

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Mild Parkinsonian signs: An overview of an emerging concept

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Gait alterations in healthy carriers of the LRRK2 G2019S mutation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Impaired trunk stability in individuals at high risk for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Incidental Lewy body disease: clinical comparison to a control cohort

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Parkinsonian signs and substantia nigra neuron density in decendents elders without PD

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Subjective complaints precede Parkinson disease: the rotterdam study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

A comparative study of LRRK2, PINK1 and genetically undefined familial Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Benign tremulous parkinsonism: a clinicopathological study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Distinguishing SWEDDs patients with asymmetric resting tremor from Parkinson's disease: a clinical and electrophysiological study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Isolated tremor and disruption of the nigrostriatal dopaminergic system: An 18F-dopa PET study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Motor signs in the prodromal phase of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Detection of presymptomatic Parkinson's disease: combining smell tests, transcranial sonography, and SPECT.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Impaired sense of smell and color discrimination in monogenic and idiopathic Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Olfaction differentiates parkin disease from early-onset parkinsonism and Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Olfactory dysfunction in LRRK2 G2019S mutation carriers

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Clinical and brain imaging characteristics in leucine-rich repeat kinase 2-associated PD and asymptomatic mutation carriers

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Parkinson's disease: a dual-hit hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Epidemiology of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected].

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Pre-motor features of Parkinson's disease: the Honolulu-Asia Aging Study experience

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Reduced cardiac 123I-MIBG scintigraphy in idiopathic REM sleep behavior disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Cardiac autonomic dysfunction in idiopathic REM sleep behavior disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Real-time visualization of altered gastric motility by magnetic resonance imaging in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

The retina in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Abnormalities in color vision and contrast sensitivity in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Multiple step pattern as a biomarker in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Morphologic changes and functional retinal impairment in patients with Parkinson disease without visual loss

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Novelty seeking and introversion do not predict the long-term risk of Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Is pre-motor diagnosis possible? The European experience

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Tracking of striatal degeneration in prediagnostic Parkinson's disease: first steps into a promising future

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

The black stuff and Konstantin Nikolaevich Tretiakoff

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Friedrich Heinrich Lewy (1885-1950) and his work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Synucleinopathies: clinical and pathological implications

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

100 years of Lewy pathology.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Staging of brain pathology related to sporadic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Autosomal recessive juvenile parkinsonism: a key to understanding nigral degeneration in sporadic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Neuropathology of Parkinson's disease with the R1441G mutation in LRRK2.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Nigral pathology and parkinsonian signs in elders without Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

A 15-year population-based cohort study of the incidence of Parkinson's disease and dementia with Lewy bodies in an elderly French cohort

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Lewy-body formation is an aggresome-related process: a hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Lewy pathology is not the first sign of degeneration in vulnerable neurons in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Role of mendelian genes in "sporadic" Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Familial parkinsonism: study of original Sagamihara PARK8 (I2020T) kindred with variable clinicopathologic outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Endoplasmic reticulum stress is important for the manifestations of α-synucleinopathy in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Clinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Lewy bodies and parkinsonism in families with parkin mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

PINK1-linked parkinsonism is associated with Lewy body pathology.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Genetic analysis of pathways to Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Neuroimaging in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

The role of inheritance in sporadic Parkinson's disease: evidence from a longitudinal study of dopaminergic function in twins.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Advances in imaging in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Voxel-wise analysis of diffusion weighted imaging reveals disruption of the olfactory tract in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Direct visualization of Parkinson's disease by in vivo human brain imaging using 7.0T magnetic resonance imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Seven-Tesla magnetic resonance images of the substantia nigra in Parkinson disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Transcranial sonography in movement disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

TCS in monogenic forms of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Enlarged substantia nigra hyperechogenicity and risk for Parkinson disease: a 37-month 3-center study of 1847 older persons

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: yes.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

Hyperechogenicity of the substantia nigra: pitfalls in assessment and specificity for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970047-4

7 January 2021

10.1016/S1474-4422(13)70047-4

Identifiers

DOI

1 reference

3 August 2017

1 reference